Where FDA Is Paying The Most Attention: Drug Safety Advisory Committee Had The Most Meetings In 2010
By
Sue Sutter / Email the Author / “The Pink Sheet” Jan. 10, 2011, Vol. 73, No. 2
Advisory Committees / Word Count: 1998 / Article # 00110110002
Executive Summary
FDA’s ongoing efforts to ramp up its focus on drug safety are being borne out at the advisory committee level, which saw a doubling in the number of meeting days for the Drug Safety and Risk Management Advisory Committee in 2010.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.